Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Half-side Comparison of Alefacept (Amevive) With or Without UVB-311nm Phototherapy in Patients With Psoriasis (Translated From German)

NCT00407342 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT00407342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Half-side Comparison of Alefacept (Amevive) With or Without UVB-311nm Phototherapy in Patients With Psoriasis (Translated From German)
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2004
Completion date
September 30, 2004
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis